Lataa...
Down-regulation of C12orf59 is associated with a poor prognosis and VHL mutations in renal cell carcinoma
C12orf59 is newly identified gene in kidney. However, the relation of C12orf59 expression and clinic features is unknown. Here, our study showed that C12orf59 was broadly expressed in normal human tissues with high expression levels in kidney while its expression is beyond detectable in a panel of c...
Tallennettuna:
| Julkaisussa: | Oncotarget |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Impact Journals LLC
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4872751/ https://ncbi.nlm.nih.gov/pubmed/26758419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6829 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|